Vection Technologies (ASX:VR1): Fairdinkum or just a fad?
Nick Sundich, March 9, 2023
Vection Technologies (ASX:VR1) is one of the few ASX stocks involved in Virtual Reality (VR).
As a result, its share price has been volatile over the years as investors wonder whether it is fairdinkum or just a fad. A trading update today might suggest it is the former, even if it is only at an early stage.
Who is Vection Technologies?
Vection Technologies has a suite of VR products aimed at businesses. Its most popular, Mindesk, helps businesses render designs in realtime VR.
The company listed on the ASX in April 2019 through a reverse takeover of ServTech, which had listed in 2016.
Its share price has been volatile ever since, going through spikes driven by individual client wins and even non-binding MoUs (Memorandums of Understanding).
The company’s finest moment was in 4Q20 when it won the Italian government as a client, to develop a remote maintenance solution for trains.
![](https://stocksdownunder.com/wp-content/uploads/2023/03/Screen-Shot-2023-03-08-at-10.16.23-am.png)
Vection Technologies (ASX:VR1) share price chart, log scale (Source: TradingView)
An intriguing week
Vection Technologies told shareholders this morning that its Total Contract Value (TCV) was ~$14m, 40% higher than it announced barely a month ago.
It also told shareholders the next two quarters would deliver strong uplift head of $24-$26m in revenue guidance. The company credited sales growth, both from new and existing customers.
It has announced several new contracts of late, most recently a ~$1m order from a top ten defence contractor – announced last Thursday.
Ultimately, we do think Vection Technologies is a fairdinkum business, although it is still not cash flow positive.
So even though it had 10 quarters of cash left as of its last quarterly cash flow report (issued in late December), longer-term investors might not be confident to gamble on this one (yet).
Blog Categories
Get Our Top 5 ASX Stocks for FY25
Recent Posts
Kamala Harris stocks: If Joe Biden’s VP wins the White House in 2024, which stocks will win?
With the US Presidential election now certain to be a Kamala Harris v Donald Trump showdown, we’ve looked at so-called…
South32 (ASX:S32): Is it the dark horse amongst ASX 200 miners or have cyclones and commodity prices hit it too hard?
South32 (ASX:S32) began life as a spinoff from BHP back in 2015, capitalised at $9bn. In mid-2024, it is capped…
Here’s why drug reimbursement is so important for ASX healthcare stocks
Let’s take a look at the concept of drug reimbursement, something that is crucial for ASX healthcare stocks looking to…